You can't put a target price on the stock until Zertane generates revenue. Wait a few months and then rely on getting a target price. Who knows what it wil be when the trials are complete. I'm glad to see the company doesn't speculate. If Zertane is approved and marketed, then they can place a target based on calculated demand. We will know pretty soon.